← Wiki Index / Microbiology & Immunology / Anaphylatoxin
🦠 Microbiology & Immunology

Anaphylatoxin

Anaphylatoxins are potent inflammatory peptide fragments—C3a, C4a, and C5a—cleaved from complement proteins during immune activation to recruit leukocytes, increase vascular permeability, and trigger mast-cell degranulation.

Anaphylatoxins are small, biologically active cationic polypeptide fragments—specifically C3a, C4a, and C5a (~74 to 77 amino acids long, ~9 to 11 kilodaltons)—generated by proteolytic cleavage of central complement system components (C3, C4, and C5) during innate immune activation. Named for their capacity to provoke rapid, systemic smooth-muscle contraction, mast-cell histamine release, and vascular leakage resembling IgE-mediated anaphylaxis, anaphylatoxins function as frontline inflammatory amplifiers that bridge humoral complement recognition with cellular leukocyte recruitment.

Among the three fragments, C5a is by far the most potent chemotactic and pro-inflammatory mediator, followed by C3a, whereas C4a exhibits substantially weaker receptor-binding activity in humans.

Proteolytic Generation and Structural Conservation

Whenever pathogens, immune complexes, or damaged host cells trigger the classical, lectin, or alternative complement pathways, enzymatic C3 convertases cleave native C3 into large opsonin C3b (which tags microbial surfaces) and soluble C3a. Subsequent assembly of C5 convertases cleaves C5 into C5b (which initiates the lytic membrane-attack complex, C5b–9) and soluble C5a.

Structurally, C3a, C4a, and C5a share a conserved four-helix bundle core stabilized by three intramolecular disulfide bridges, terminating in a flexible C-terminal tail ending in an arginine residue (Arg77 in C3a; Arg74 in C5a) required for high-affinity receptor engagement.

Receptor Signaling and Physiological Effects

Anaphylatoxins signal through seven-transmembrane G-protein-coupled receptors (GPCRs)—principally C3aR and C5aR1 (CD88)—expressed on mast cells, basophils, neutrophils, monocytes, macrophages, and vascular endothelial cells:

  • Vascular Permeability and Smooth Muscle Contraction: Binding to C3aR and C5aR1 on tissue mast cells and basophils triggers rapid degranulation, liberating histamine, leukotrienes, and platelet-activating factor that dilate arterioles and open endothelial junctions so plasma proteins and antibodies flood infected tissues.
  • Leukocyte Chemotaxis and Oxidative Burst: C5a forms a potent chemotactic gradient guiding neutrophils and monocytes out of capillaries, upregulates CR3 (CD11b/CD18) integrins for firm endothelial adhesion, and primes the NADPH oxidase respiratory burst and cytokine release (TNF-alpha, IL-1 beta, IL-6).
  • Inactivation by Carboxypeptidases: To prevent runaway systemic shock, circulating plasma carboxypeptidase N and carboxypeptidase B2 (TAFI) promptly cleave the C-terminal arginine off C3a and C5a, converting them into C3a-desArg (which loses anaphylatoxin activity) and C5a-desArg (retaining ~1 to 10 percent potency).

Pathological Roles in Sepsis, Asthma, and Complement Therapeutics

Excessive systemic anaphylatoxin generation drives capillary leak, neutrophil-mediated endothelial injury, and immunothrombosis in bacterial sepsis, acute respiratory distress syndrome (ARDS), ischemia-reperfusion injury, and ANCA-associated vasculitis. Consequently, monoclonal antibodies targeting C5 cleavage (eculizumab) and small-molecule C5aR1 antagonists (avacopan) have entered clinical medicine to block pathological C5a signaling while preserving upstream C3b opsonization.

Crosstalk with Adaptive Immunity and Coagulation Cascades

Beyond acute innate inflammation, anaphylatoxins regulate adaptive T-cell and B-cell responses and immunothrombosis. Locally generated C3a and C5a act directly on C3aR and C5aR1 expressed by dendritic cells and naive CD4+ T cells, providing co-stimulatory survival signals that promote Th1 and Th17 differentiation while suppressing regulatory T-cell (Treg) induction. Simultaneously, C5a stimulates vascular endothelial cells and monocytes to express tissue factor (CD142) and release neutrophil extracellular traps (NETs), linking complement activation directly to microvascular coagulation during pronounced bacterial sepsis and thrombotic microangiopathies.

Homeostatic Roles in Tissue Regeneration and Synaptic Pruning

Recent neuroimmunology and regenerative-biology research demonstrates that low-level tonic anaphylatoxin signaling also performs non-inflammatory physiological functions. Following partial hepatectomy or toxic liver injury, C3a and C5a signaling on Kupffer cells and hepatocytes primes IL-6 and TNF-alpha pathways essential for rapid liver regeneration. Similarly, local complement activation in the developing central nervous system guides microglia-mediated synaptic pruning and neural-crest cell migration.

Frequently Asked Questions

How does C5a differ from C3a in immune potency?

C5a is roughly 10- to 100-fold more potent than C3a on a molar basis, acts as the dominant complement-derived neutrophil chemoattractant, and retains partial signaling activity even after conversion to C5a-desArg.

Why are anaphylatoxins named after anaphylaxis if they do not require IgE?

Early immunologists observed that injecting complement-activated serum into guinea pigs produced acute bronchospasm, vasodilation, and shock identical to IgE-mediated anaphylactic shock—hence "anaphylatoxin" (anaphylaxis-like toxin).

What is the function of C5aR2 (C5L2)?

C5aR2 is an atypical seven-transmembrane receptor that lacks canonical G-protein coupling and acts both as a decoy scavenger clearing excess C5a/C5a-desArg and as a beta-arrestin modulator of C5aR1 inflammation.

How is C5a cleared rapidly from healthy human plasma?

Within seconds to minutes of cleavage, plasma carboxypeptidase N removes C5a's C-terminal arginine residue, while C5aR1 and decoy receptor C5aR2 internalize and degrade bound ligand to confine inflammation locally.

What happens in genetic C3 or C5 deficiency?

Individuals with rare genetic deficiencies in C3 or C5 cannot generate C3a or C5a anaphylatoxins, leading to impaired neutrophil recruitment, defective opsonization (for C3), and heightened susceptibility to recurrent encapsulated bacterial infections such as Neisseria meningitidis.

References

  1. Hugli, T. E. (1985). Structure and Function of the Anaphylatoxins. Complement (Springer). https://doi.org/10.1007/978-3-642-82416-6_5
  2. Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009). The role of the anaphylatoxins in health and disease. Molecular Immunology, 46(14), 2753–2766. https://doi.org/10.1016/j.molimm.2009.04.027
  3. Bajic, G., Yatime, L., Klos, A., & Andersen, G. R. (2012). Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg. Protein Science. https://doi.org/10.1002/pro.2200
🧬 Support Open Science
Explore interactive science games on LowKey Games or browse scientific apparel & accessories in the CRV Science Shop.
💡 Spot an inaccuracy or have primary literature to expand this article?
Submit a citation or revision note using your shared CRV Science / LowKey Games profile ID.
Suggest Revision